NCT03110029

Evaluating the Efficacy and Compatibility of Efinaconazole 10% Solution (Jublia) for the Treatment of Toenail Onychomycosis in Patients Wearing Toenail Polish Compared to Those Without Polish

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 13 (actual)
• Sponsor: University of Alabama at Birmingham · Academic / Other
• Sex: Female
• Age: 19 Years – 70 Years
• Healthy volunteers: Accepted

Summary

This study will test how well efinaconazole solution (Jublia) works to treat toenail fungal infections in patients who wear polish compared to those who do not.

Detailed description

Topical efinaconazole 10% solution is known to be an efficacious and safe treatment modality for toenail onychomycosis. This study will examine the compatibility of topical efinaconazole and nail polish in patients with distal and lateral subungual onychomycosis (DLSO). It is hypothesized that the treatment of DLSO with efinaconazole 10% solution will not be adversely affected by the application of nail polish.

Conditions

• Onychomycosis of Toenail

Interventions

Type	Name	Description
DRUG	Efinaconazole 10% Topical Application Solution [JUBLIA]	Topical efinaconazole 10% solution (Jublia)
OTHER	Application of Nail Polish	Application of Nail Polish

Timeline

• Start date: 2015-09-01
• Primary completion: 2017-05-01
• Completion: 2018-07-01
• First posted: 2017-04-12
• Last updated: 2019-06-27
• Results posted: 2019-03-20

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study